Issuance of new reimbursement-related codes expected to accelerate the use and adoption of ECG-based cardiac dysfunction AI algorithms, including HeartSciences’ MyoVista October 19, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences, a…
Issuance of new reimbursement-related codes expected to accelerate the use and adoption of ECG-based cardiac dysfunction AI algorithms, including HeartSciences’ MyoVista SOUTHLAKE, Texas, Oct. 19, 2022 — Heart Test Laboratories, Inc. d/b/a…
Southlake, Texas–(October 18, 2022) – Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS) (NASDAQ: HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG…
Southlake, Texas, October 6, 2022, (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on applying innovative AI-based…
NEW BRUNSWICK — Robert Wood Johnson University Hospital and Rutgers Robert Wood Johnson Medical School have teamed up to launch a new model for medical research and innovation called The…
HeartSciences Pumps Life into Assessing Diastolic Dysfunction with New AI Patent » Dallas Innovates Southlake-based HeartSciences, which closed on a $6.375M IPO in June, applies AI-based technology to an ECG to…
